key: cord-0927881-0tjugh6e authors: Mena‐Tudela, Desirée; Aguilar‐Camprubí, Laia; Quifer‐Rada, Paola; Paricio‐Talayero, José María; Padró‐Arocas, Alba title: The COVID‐19 vaccine in women: Decisions, data and gender gap date: 2021-03-28 journal: Nurs Inq DOI: 10.1111/nin.12416 sha: 8e5fc6a88fa26a3ef218818000baed3a09b3237a doc_id: 927881 cord_uid: 0tjugh6e nan The year 2020 will be recorded in memory and world history as the COVID-19 (World Health Organization, 2020b) . Pregnant women experience immunological and physiological changes that may make them more susceptible to COVID-19 and to develop obstetric complications with adverse perinatal outcomes (Kotlar et al., 2021) . The first case of the COVID-19 disease presented with fever, dry cough, dyspnea, and bilateral pulmonary infiltrates (World Health Organization, 2020a) with no apparent differences in clinical picture and evolution of the disease between pregnant women and the rest of the population (Kotlar et al., 2021) . On the other hand, since the beginning of the pandemic, the initiation and maintenance of breastfeeding has been recommended by various organizations such as the World Health Organization (World Health Organization, 2020a) and the strong immunological response of the female body to has been subsequently demonstrated with the passing of antibodies against SARS-CoV-2 into breast milk (Fox et al., 2020) . SARS-CoV-2 has highlighted already existing gender inequalities, particularly in the field of care (Escuriet et al., 2020; O'Sullivan et al., 2009 ). Moreover, women represent 70% of health care workers worldwide and 80% of nurses in most regions (Boniol et al., 2019) , with this profession engaging in particularly close contact with sick patients. Considering these data, not contemplating data collection and research in pregnant and breastfeeding women appears to be a fundamental mistake. The World Health Organization has already warned that this important gender data gap in research in previous epidemics would be crucial in subsequent pandemics (World Health Organization & Regional Office for the Western Pacific, 2011). It is important to reflect that the systematic exclusion of pregnant and lactating women from research is probably derived from the abuses in research in the middle of the last century (Modi et al., 2021) . But this approach must be adapted to the real emergencies of epidemic outbreaks where an imminent response is needed, that must be driven by innovative and updated approaches, as was the case with the Zika and Ebola virus (Krubiner et al., 2021) . These new approaches should also contemplate the separation of research on pregnant or lactating women, and it should be noted that, if studies on pregnancy conclude that this circumstance is a contraindication for vaccination, lactation should not automatically be considered in the same category. Likewise, it is not logical to depend on studies of pregnant women to make decisions on its use in breastfeeding mothers (Hospital Infant Feeding Network, 2021) . On the other hand, in Spain we have two digital tools that seem to be key in supporting lactation among women: LactApp and e-lactancia. Since their creation, both digital tools have received thousands of visits and often medical and nursing professionals alike also make use of these tools (Padró-Arocas et al., 2021; Paricio-Talayero et al., 2020) . The teams of lactation professionals at LactApp and e-lactancia have developed information on COVID-19, its vaccination, and its possible compatibility with breastfeeding in their respective websites and apps, that aim to empower women through scientific evidence in their decisionmaking process regarding breastfeeding by offering them reliable and updated information. On the website e-lactancia.org, the section entitled "Maternal It appears that the constant visits and the exponential increase in visits to both e-lactancia and LactApp speak by themselves for a need of reliable and validated information on the compatibility of lactation and the COVID-19 vaccine. The evolution of the pandemic, the monitoring of cases in almost real time worldwide, and the development of a vaccine against a microbiological agent that has damaged our lives in just a few months have been a true revolution. To carry out the development of this vaccine, enormous efforts have been made to ensure its approval and distribution. The vaccination strategy has been organized on an individual level for each country, starting with the most important general criteria for the most vulnerable population or most exposed to COVID-19, such as health care workers (Modi et al., 2021) . Among these health care workers, the majority are female nurses of reproductive age (World Health Organization & Regional Office for the Western Pacific, 2011). Despite multiple petitions calling for changes, reformation of legal frameworks and action on the inclusion of pregnant and lactating women in COVID-19 trials and vaccine development (Heath et al., 2020; Whitehead & Walker, 2020) , these requests seem to have been overlooked. Women, once again, are in second place of attention in terms of policy and research. Thus, the overprotection of women and the seemingly prevailing paternalism, especially for pregnant and lactating women, potentially undermine their sexual and reproductive health, by acting in a harmful way to such important Gender equity in the health workforce: Analysis of 104 countries. Working paper 1. World Health Organization COVID's collateral damage on women's health: How to resume the path of improvement Robust and specific secretory IgA against SARS-CoV-2 detected in human milk. iScience Inclusion of pregnant women in COVID-19 vaccine development. The Lancet Infectious Diseases Archived: Statement from the GP Infant Feeding Network, the Hospital Infant Feeding Network and Breastfeeding for Doctors The impact of the COVID-19 pandemic on maternal and perinatal health: A scoping review Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response COVID-19 Precautions hamper breastfeeding support Perspectives of pregnant and breastfeeding women on longitudinal clinical studies that require non-invasive biospecimen collection: A qualitative study Equity in Covid-19 vaccine development and deployment If schools are closed, who will watch our kids? Family caregiving and other sources of role conflict among nurses during large-scale outbreaks Telelactation with a mobile app: User profile and most common queries. Breastfeeding Medicine. Advance online version Is it compatible with breastfeeding? www.e-lactancia.org: Analysis of visits, user profile and most visited products President's corner: Introduction to ABM's statement on considerations for COVID-19 vaccination in lactation Consider pregnancy in COVID-19 therapeutic drug and vaccine trials Taking sex and gender into account in emerging infectious disease programmes: An analytical framework. World Health Organization Home care for patients with COVID-19 presenting with mild symptoms and management of contacts: Interim guidance. Department of Communications, WHO Worldwide WHO Director-General's opening remarks at the media briefing on COVID-19 -11